- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07293650
PREcision MEDicine In Achalasia (PREMEDIA) (PREMEDIA)
PREcision MEDicine In Achalasia - Studio Clinico Multicentrico Randomizzato di Non-Inferiorità di POEM Breve Personalizzato vs. POEM Standard per l'Acalasia Non-Spastica e Studio di Coorte Prospettico Multicentrico di POEM Lungo Personalizzato per i Disturbi Motori Esofagei Spastici
The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:
- Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms?
- Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.
Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The investigators will perform a randomized controlled trial to compare two different approaches to Peroral Endoscopic Myotomy (POEM) for treating achalasia (Types I and II) and esophagogastric junction outflow obstruction (EGJOO). The most widely used treatment for achalasia is POEM but the current approach involves a 9 cm (3.5 inch) myotomy (cutting of the muscle) to open up the tight lower esophageal sphincter to promote food delivery from the esophagus to the stomach. This approach is very effective, with success rates of approximately 90% over the short term. However, the investigators believe that POEM does not require a full 9 cm myotomy and that the investigators can cut much less muscle (approximately 4cm/1.25inches) to achieve similar improvement in symptoms but with less long-term complications. Cutting less muscle may result in less acid reflux, which is the Achilles heel of any successful treatment for achalasia. A shorter muscle cut may also result in less of a complication known as blown-out myotomy, which causes failure of the esophagus to empty its contents and is a major cause of long-term symptom relapse. The investigators have designed this study to determine whether the shorter myotomy (4 cm) is equivalent to the longer myotomy (9 cm) in terms if symptom improvement, but with the possibility of less acid reflux and blown-out myotomy.
Given these questions, the investigators will enroll 370 patients in a randomized trial where patients will receive either the short tailored (4cm/1.25 inches) or the standard myotomy (9cm/3.5 inches). All patients will undergo intraoperative assessment of success of the myotomy by using a special tool called the functional lumen imaging probe (FLIP). The FLIP will measure the opening dimensions of the lower esophageal sphincter and ensure that the myotomy is adequately performed so that the lower esophageal sphincter can open to a level that will improve esophageal emptying/swallowing. The investigators will follow patients for 2 years in a manner similar to how the investigators would follow patients after achalasia treatment in standard clinical practice. The investigators will assess whether symptoms are similar and whether or not there are differences in acid reflux and esophageal emptying. Patients will undergo follow up testing with questionnaires at intervals of 3-6 months over two years and they will have reflux testing (measure acid exposure using a capsule placed during endoscopy) between 6-12 months and a barium esophagram (X ray while drinking barium) at 2 years. The most important aim is to prove that the symptoms and outcomes success/failure) between the two approaches are similar (short myotomy is non-inferior) and the Eckardt score will be the primary questionnaire score for this study. The investigators believe that this study will help define the optimal approach to POEM in achalasia and also help us prevent complications in the future.
Additionally, the investigators will also ask participants to provide a sample of the muscle tissue that is typically cut during the POEM. This tissue will help us develop a tissue bank to help other researchers looking into the causes of why achalasia and these other esophageal diseases occur. The participants can opt out of this part and still continue in the randomized controlled trial.
Tipo di studio
Iscrizione (Stimato)
Fase
- Fase 3
Contatti e Sedi
Contatto studio
- Nome: Elizabeth Yan, BS
- Numero di telefono: 312-908-1723
- Email: premedia.dcc@northwestern.edu
Backup dei contatti dello studio
- Nome: Yasmin Pina, BS
- Numero di telefono: 312-503-6459
- Email: premedia.dcc@northwestern.edu
Luoghi di studio
-
-
Arizona
-
Scottsdale, Arizona, Stati Uniti, 85259
- Non ancora reclutamento
- Mayo Clinic Arizona
-
-
California
-
La Jolla, California, Stati Uniti, 92037
- Reclutamento
- University of California San Diego
-
Investigatore principale:
- Rena Yadlapati, MD
-
Contatto:
- Alexander Gonsalves, Lead Study Coordinator
- Numero di telefono: 858-246-5236
- Email: PREMEDIA@health.ucsd.edu
-
-
Colorado
-
Denver, Colorado, Stati Uniti, 80217
- Non ancora reclutamento
- University of Colorado Denver
-
-
Florida
-
Gainesville, Florida, Stati Uniti, 32611
- Reclutamento
- University of Florida
-
Investigatore principale:
- Peter Draganov, MD
-
Contatto:
- April Goddard, Lead Study Coordinator, PA-C
- Numero di telefono: 352-273-9483
- Email: DOM-GIResereachTeam@ad.ufl.edu
-
Orlando, Florida, Stati Uniti, 32803
- Non ancora reclutamento
- Adventist Health System/Sunbelt, Inc
-
-
Georgia
-
Atlanta, Georgia, Stati Uniti, 30322
- Reclutamento
- Emory University
-
Investigatore principale:
- Anand Jain, MD
-
Contatto:
- Halley Fowler, Lead Study Coordinator
- Numero di telefono: 404-778-3184
- Email: halley.fowler@emory.edu
-
-
Illinois
-
Chicago, Illinois, Stati Uniti, 60611
- Reclutamento
- Northwestern University
-
Investigatore principale:
- John Pandolfino, MD
-
Contatto:
- Eric Pfannkuche, Lead Study Coordinator
- Numero di telefono: 312-926-4525
- Email: PREMEDIA@northwestern.edu
-
-
Maryland
-
Baltimore, Maryland, Stati Uniti, 21218
- Non ancora reclutamento
- Johns Hopkins University
-
-
Massachusetts
-
Boston, Massachusetts, Stati Uniti, 02114
- Reclutamento
- Massachusetts General Hospital
-
Contatto:
- Madison Paylor, Lead Study Coordinator
- Numero di telefono: 617-726-0196
- Email: premedia@mgb.org
-
Investigatore principale:
- Kyle Staller, MD
-
-
Missouri
-
St Louis, Missouri, Stati Uniti, 63110
- Reclutamento
- Washington University
-
Contatto:
- Darren Nix, Lead Study Coordinator
- Numero di telefono: 314-273-1432
- Email: Premediasurgerytrial@wustl.edu
-
Investigatore principale:
- Chandra Gyawali, MD
-
-
New York
-
New York, New York, Stati Uniti, 10065
- Non ancora reclutamento
- Weill Cornell Medical College
-
-
North Carolina
-
Charlotte, North Carolina, Stati Uniti, 28204
- Reclutamento
- Atrium Health/Wake Forest
-
Investigatore principale:
- Badih Elmunzer, MD
-
Contatto:
- Greg Scarola, Lead Study Coordinator
- Numero di telefono: (704) 355-2000
- Email: PREMEDIA@advocatehealth.org
-
-
Ohio
-
Cleveland, Ohio, Stati Uniti, 44109
- Reclutamento
- MetroHealth Medical Center
-
Investigatore principale:
- Ronnie Fass, MD
-
Contatto:
- Stephanie Baker, Lead Study Coordinator
- Numero di telefono: 216-778-5736
- Email: premedia@metrohealth.org
-
Cleveland, Ohio, Stati Uniti, 44106
- Non ancora reclutamento
- Case Western Reserve University
-
-
Tennessee
-
Nashville, Tennessee, Stati Uniti, 37232
- Reclutamento
- Vanderbilt University Medical Center
-
Investigatore principale:
- Dhyanesh Patel, MD
-
Contatto:
- Larry Raber, Lead Study Coordinator
- Numero di telefono: 615-322-4643
- Email: larry.w.raber@vumc.org
-
-
Texas
-
Dallas, Texas, Stati Uniti, 75246
- Reclutamento
- Baylor Scott & White Health
-
Contatto:
- Neomy Flores, Lead Study Coordinator
- Numero di telefono: 214-820-9704
- Email: premedia@bswhealth.org
-
Investigatore principale:
- Vani Albertson Konda, MD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria
- Age ≥ 18
- Type I achalasia or type II achalasia or cEGJOO
- Eckardt score > 3
Exclusion Criteria
The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
- Prior POEM
- Prior surgical treatment for achalasia
- Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
- Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
- Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
- Known secondary achalasia related to malignancy (pseudoachalasia)
- Known eosinophilic esophagitis
- Diverticulum (> 2 cm) in distal esophagus
- Megaesophagus
- Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
- Pregnancy
- Standard contraindications to general anesthesia
- Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
- Unwillingness or inability to consent for the study
- Anticipated inability to follow protocol
- Weekly (or more frequent) opioid medication use in the last 2 years
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Quadruplicare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Miotomia Standard
|
Myotomy during POEM of 8-10 cm in length, extending 2-3 cm into the gastric cardia; intention to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
|
Sperimentale: Miotomia Breve Personalizzata
|
Myotomy during POEM of 4-5 cm in length, extending 1-2 cm into the gastric cardia; intend to perform selective circular myotomy, but allowing full thickness myotomy. FLIP is used to confirm adequate myotomy. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Clinical Response-Overall
Lasso di tempo: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Sex
Lasso di tempo: From enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From enrollment to Year 2
|
|
Clinical Response-by Race
Lasso di tempo: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
|
Clinical Response-by Ethnicity
Lasso di tempo: From Enrollment to Year 2
|
Clinical Response is defined by the Eckardt score (a 4-item self-report scale measuring weight loss, chest pain, regurgitation, and dysphagia) with no need for retreatment in 2 years. |
From Enrollment to Year 2
|
Collaboratori e investigatori
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- PREMEDIA (Pro00083748) - 01
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
- RSI
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .